Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
-5.86%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$15.7B
AUM Growth
+$2.71B
(+21%)
Cap. Flow
+$3.21B
Cap. Flow
% of AUM
20.44%
Top 10 Holdings %
Top 10 Hldgs %
9.72%
Holding
3,246
New
825
Increased
763
Reduced
767
Closed
833
Top Buys
| 1 |
Visa
V
|
+$148M |
| 2 |
Coca-Cola
KO
|
+$140M |
| 3 |
McDonald's
MCD
|
+$126M |
| 4 |
Mondelez International
MDLZ
|
+$112M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$99.1M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
+$184M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$125M |
| 3 |
Workday
WDAY
|
+$107M |
| 4 |
ConocoPhillips
COP
|
+$95.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$95M |
Sector Composition
| 1 | Technology | 22.08% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 11.46% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Emerald Holding
EEX
$960M
| $67K | ﹤0.01% |
19,884
-3,491
| -15% | -$11.8K |
|
2027
iShares S&P India Nifty 50 Index Fund
INDY
$653M
| $67K | ﹤0.01% |
+1,599
| New | +$67K |
|
2028
Kopin
KOPN
$366M
| $67K | ﹤0.01% |
63,819
-11,606
| -15% | -$12.2K |
|
2029
Global X SuperDividend REIT ETF
SRET
$200M
| $67K | ﹤0.01% |
3,235
+600
| +23% | +$12.4K |
|
2030
Akebia Therapeutics
AKBA
$777M
| $66K | ﹤0.01% |
209,755
-388,624
| -65% | -$122K |
|
2031
VirnetX
VHC
$74.6M
| $66K | ﹤0.01% |
2,811
-373
| -12% | -$8.76K |
|
|
DMTK
2032
DELISTED
DermTech, Inc. Common Stock
DMTK
| $66K | ﹤0.01% |
16,735
-21,777
| -57% | -$85.9K |
|
2033
SPDR NYSE Technology ETF
XNTK
$1.32B
| $65K | ﹤0.01% |
+695
| New | +$65K |
|
2034
Adverum Biotechnologies
ADVM
$69.5M
| $64K | ﹤0.01% |
6,756
-1,633
| -19% | -$15.5K |
|
2035
DarioHealth
DRIO
$17M
| $64K | ﹤0.01% |
691
-88
| -11% | -$8.15K |
|
2036
iShares US Financial Services ETF
IYG
$1.94B
| $64K | ﹤0.01% |
1,356
-522
| -28% | -$24.6K |
|
2037
Neuronetics
STIM
$228M
| $64K | ﹤0.01% |
19,999
-2,686
| -12% | -$8.6K |
|
2038
Terns Pharmaceuticals
TERN
$654M
| $64K | ﹤0.01% |
10,809
-599
| -5% | -$3.55K |
|
2039
Cantaloupe
CTLP
$789M
| $63K | ﹤0.01% |
+17,976
| New | +$63K |
|
2040
First Trust Utilities AlphaDEX Fund
FXU
$1.71B
| $63K | ﹤0.01% |
2,053
+71
| +4% | +$2.18K |
|
2041
iShares Morningstar Growth ETF
ILCG
$3B
| $63K | ﹤0.01% |
1,300
-917
| -41% | -$44.4K |
|
2042
Puma Biotechnology
PBYI
$229M
| $63K | ﹤0.01% |
26,545
-2,765
| -9% | -$6.56K |
|
2043
iShares Mortgage Real Estate ETF
REM
$614M
| $63K | ﹤0.01% |
+2,991
| New | +$63K |
|
|
LENZ
2044
LENZ Therapeutics
LENZ
$1.19B
| $63K | ﹤0.01% |
2,856
+336
| +13% | +$7.41K |
|
|
OMGA
2045
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $63K | ﹤0.01% |
11,618
-2,001
| -15% | -$10.9K |
|
2046
WisdomTree US SmallCap Earnings Fund
EES
$645M
| $62K | ﹤0.01% |
1,582
+1,493
| +1,678% | +$58.5K |
|
2047
NatWest
NWG
$58B
| $62K | ﹤0.01% |
+12,374
| New | +$62K |
|
2048
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$598M
| $62K | ﹤0.01% |
1,505
-3,700
| -71% | -$152K |
|
2049
Carisma Therapeutics
CARM
$15.8M
| $61K | ﹤0.01% |
7,221
-1,271
| -15% | -$10.7K |
|
2050
Innodata
INOD
$1.94B
| $61K | ﹤0.01% |
20,228
+3,220
| +19% | +$9.71K |
|